Authors


Nicholas B. Norgard, PharmD, BCPS

Latest:

Antiplatelet Agents in Acute Coronary Syndrome: Interventions for Hospital and Community Pharmacists

This Continuing Education activity is supported by an educational grant from Merck, Sharp and Dohme Corp.


Larry Hausner, MBA

Latest:

The Global Fight for a Healthier World

Last year's historic UN meeting set the stage for the fight against noncommunicable diseases. What are our next steps in stopping this slow-moving hurricane?



Lourdes Cross, PharmD, BCACP, CDE

Latest:

Recommendations for Counseling Traveling Patients with Diabetes

According to the ADA, best practice is to pack at least twice as much medications and glucose testing supplies as normally needed to minimize complications due to travel delays or lost luggage.3 Many manufacturers of insulin pumps will provide a loaner for international travel.


Lincy S. Lal, PhD, PharmD

Latest:

Outcomes of a Specialty Pharmacy Program for Oral Oncology Medications

Our research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.


Daya Kappil, RPh

Latest:

10 Strategies for Minimizing Dispensing Errors

Dispensing errors can be costly for the pharmacist as well as potentially dangerous for the patient. Pharmacists can take simple steps to help eliminate this problem.


Brian Gifford, PhD

Latest:

Specialty Pharmaceuticals: An Agenda for Health and Productivity Research

This commentary proposes a research agenda that could inform policymaking based on a broader understanding the economic and social costs and benefits of specialty pharmaceuticals.




Arthi B. Chandran, MS, MPH

Latest:

Healthcare Utilization and Costs for Insured Patients With Fibromyalgia

Fibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.


Catherine Meininger, 2018 PharmD Candidate

Latest:

What Pharmacy Students Need to Know about MTM

Medication therapy management has become an important buzzword in the world of pharmacy.


Jennifer Nessel, Assistant Editors

Latest:

Manufacturers Launch Programs to Allow Greater Access to Insulin in Response to COVID-19

In response to the financial crisis driven by the coronavirus disease 2019 (COVID-19) pandemic, drug manufacturers are aiming to increase access to insulin products.


Mary Ellen Roberts, RN, MSN

Latest:

Patient Adherence: Identifying Barriers and Defining Solutions

Major patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.


Anthony Palmieri, PharmD, RPh, MBA

Latest:

Oral Oncology: Utilization of Selected Oral Antineoplastic Enzyme Inhibitor Agents

An overview of the utilization and cost for selected oral antineoplastic agents, with discussion regarding oncology in general, as well as the topic of adherence.


Craig Cocchio, PharmD

Latest:

Giapreza: A Look at the Pharmacology of Ang2

Angiotensin-II is the newest vasopressor available on the market.


Lauren Santye, Assistant Editor & Laurie Toich, Assistant Editor

Latest:

What are the Implications of Transparency Legislation on Specialty Pharmacy?

Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how recently proposed transparency legislation may affect specialty pharmacies.




CEO, D2 Consulting

Latest:

Responding Proactively to Antikickback Guidelines

The time has come to be proactive in finding a path that can benefit all potential stakeholders, rather than letting other third parties define the system in a way that negatively affects potential outcomes.



Lesa Mitchell, BA

Latest:

"Here Us Now:" The Patient Community Has Spoken

A new documentary has been released that underscores the need for accelerating alternative pathways for new discoveries that hold the promise for curing patients.



Caitlyn Bloom, PharmD

Latest:

OTC Focus Case Studies: Cancer

Prostate cancer prevention, irinotecan-induced diarrhea, smoking cessation, and more.


Jake Nichols, PharmD, MBA

Latest:

Cost and Utilization Outcomes Associated With a Dosage Consolidation and Quantity Limits Program

Dose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.



Laurie Wade, PharmD Candidate, Mary Barna Bridgeman, PharmD, BCPS, CGP

Latest:

Novel Tactics: Deterring Opioid Abuse

Since the introduction of the new formulation of OxyContin, drug makers have sought innovative ways to curb the abuse of painkillers.



Anthony Palmieri, PharmD, MBA, RPh

Latest:

Prescription Utilization of the Oral Anticoagulants

New and forthcoming oral anticoagulants, which do not require prothrombin time monitoring, will offer patients and providers additional therapeutic options.


Renee N. Saris-Baglama, PhD

Latest:

A Computerized Asthma Outcomes Measure Is Feasible for Disease Management

The ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.


Ryan Swanson, PharmD

Latest:

The Greatest Profession

Touted by U.S. News & World Report as a top career for 2009, pharmacy offers unique opportunities for growth and professional fulfillment.